BIOTIME, INC 8-K 10-8-2015

Company

Lineage Cell Therapeutics, Inc.

Filed

October 15, 2015

Period of Report

October 8, 2015

Accession Number

0001140361-15-037739

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →